Live starting prices
← Back to Tools

GLP-1 Savings Calculator, Compare Your Options

Compare what you pay with current, complete published monthly prices.

The multi-month result is a simple illustration, not a quote or guarantee of eligibility, availability, treatment duration, or future pricing.

1. What are you currently paying?

Select a common scenario or enter a custom amount.

Or enter exact amount:
$/mo

2. Choose an illustration period

We multiply today's monthly difference. Prices and treatment duration can change.

3. Do you have insurance?

This changes the guidance below. Unverified copays, Medicare benefits, and savings-card amounts are not used in the arithmetic.

How to Pay Less for GLP-1 Medications

1. Check your insurance formulary

Many commercial plans now cover Wegovy and Zepbound for weight management. Call the number on your insurance card and ask specifically about anti-obesity medication coverage. Even plans that denied coverage in 2024 may have updated their formularies for 2026.

2. Check manufacturer savings-card terms

Novo Nordisk and Eli Lilly publish savings offers for some commercially insured patients. Eligible medication, plan type, benefit amount, annual limit, refill rules, and offer duration vary. Verify the current terms; this calculator does not assume a card price.

3. Consider compounded alternatives

Compounded semaglutide and tirzepatide can cost less, but they are not FDA-approved and should not be treated as proven equivalents to the brands. Formulation, sourcing, and pharmacy oversight vary. Verify the patient-specific prescription and dispensing pharmacy; 503B outsourcing facilities are FDA-registered, not FDA-licensed.

4. Check Medicare Bridge eligibility

The Medicare GLP-1 Bridge program went live in July 2026 with published costs of approximately $50/mo for eligible beneficiaries. Confirm medication coverage and individual eligibility; this calculator does not treat the Bridge amount as a guaranteed monthly price.

5. Compare telehealth providers

Published prices vary dramatically between telehealth platforms. Compare the ongoing all-in cost, medication and dose, introductory versus renewal price, required commitment, shipping, and clinical support—not just the lowest headline number.

Price Trends: GLP-1 Costs Are Dropping

GLP-1 medication prices have been falling steadily since late 2024. Eli Lilly launched Zepbound self-pay vials at $399/mo (later reduced further). Novo Nordisk responded with competitive pricing. The compounded market has driven prices below $200/mo for many patients.

A major 2026 shift is Medicare coverage, live as of July 2026. The GLP-1 Bridge program provides transitional coverage for Medicare beneficiaries at approximately $50/mo. That's a game changer for the 65+ population that has been largely priced out of these medications. Full Part D coverage for anti-obesity medications is expected to follow. (See our Medicare coverage checker.)

Competition is also increasing. Orforglipron (Eli Lilly's oral GLP-1) is now available as Foundayo, and several new GLP-1/GIP dual agonists are in late-stage trials. More options mean more pricing pressure. Expect costs to continue declining through 2026 and 2027.

Want today's lowest prices? Compare all providers by price.

Frequently Asked Questions

What is the cheapest way to get GLP-1 medication?
The cheapest route depends on the prescribed drug, dose, coverage, and eligibility. The lowest complete published telehealth price in this comparison is $175/mo month-to-month, but that does not establish availability or clinical eligibility. Manufacturer savings cards may reduce some commercially insured patients' costs; this calculator does not assume a card or copay amount.
How much does Wegovy cost without insurance?
Wegovy's current manufacturer list price is $1,349/mo. NovoCare self-pay: pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent. The calculator does not extrapolate an introductory or dose-dependent self-pay price across multiple months. Compounded products can cost less but are not FDA-approved substitutes or proven equivalents.
Will Medicare cover GLP-1 medications in 2026?
The Medicare GLP-1 Bridge program went live in July 2026 with published costs of approximately $50/mo for eligible beneficiaries. Medication coverage and individual eligibility must be verified; the calculator does not use the Bridge amount in its projection.
Is compounded semaglutide as effective as Wegovy?
That has not been established. Wegovy's efficacy evidence comes from the FDA-approved product. Compounded semaglutide is not FDA-approved, and formulation, source, testing, and bioavailability can differ. Ask the prescriber which pharmacy dispenses the product and what evidence supports that exact formulation.
How can I save the most on GLP-1 medications?
First confirm the prescribed medication, dose, formulary coverage, prior-authorization rules, and your actual copay. Then check the manufacturer's current savings-card terms and benefit limits. If paying cash, compare complete ongoing prices rather than introductory or medication-excluding figures. Medicare Bridge eligibility must be verified separately.

Ready to find your best option?

Our match quiz considers your budget, insurance, medication preference, and priorities to recommend the right provider.

Disclaimer: Manufacturer list-price rows use our canonical source checks dated through August 14, 2026; telehealth rows use complete published prices from our provider database. Savings-card amounts, insurance copays, Medicare benefits, introductory prices, and medication-excluding fees are not used in the projection because eligibility, limits, and duration cannot be verified here. Multi-month figures simply multiply today's monthly difference and are not quotes or guarantees. Actual costs vary by medication, dose, insurance plan, pharmacy, location, and clinical eligibility. This tool is informational and is not financial or medical advice. Verify pricing with the provider, manufacturer, pharmacy, and insurer before making a treatment decision.

Featured Partners

Four affiliate partners we feature, we may earn a commission.

Embody

7.3/10
from $69/mo·Compounded

Gala

7.2/10
from $149/mo·Brand & Compounded

Ro

7.2/10
$149/mo membership + medication·Brand

Affiliate links, we earn a commission at no extra cost to you. These are featured partners, prioritized by our affiliate economics, not an editorial "best" ranking. The objective ranking (by methodology score) and full methodology are at glp1picks.com/best.